Abstract
Endometrial carcinoma is a rare iatrogenic complication due to the adverse estrogenic like effect of Tamoxifen on the uterine mucosa. We report the delayed case of an endometrial carcinoma after an unusual twleve year long daily administration of Tamoxifen (cumulative dose = 131 g). Endovaginal contrast ultrasound examination (Levovist, Schering, Germany) and MRI appearances are described.
Publication types
-
Case Reports
-
Comparative Study
MeSH terms
-
Adenocarcinoma / chemically induced*
-
Adenocarcinoma / diagnosis*
-
Adenocarcinoma / diagnostic imaging*
-
Adenocarcinoma / radiotherapy
-
Adenocarcinoma / surgery
-
Antineoplastic Agents, Hormonal / administration & dosage
-
Antineoplastic Agents, Hormonal / adverse effects*
-
Brachytherapy
-
Combined Modality Therapy
-
Contrast Media
-
Endometrial Neoplasms / chemically induced*
-
Endometrial Neoplasms / diagnosis*
-
Endometrial Neoplasms / diagnostic imaging*
-
Endometrial Neoplasms / radiotherapy
-
Endometrial Neoplasms / surgery
-
Female
-
Humans
-
Hysterectomy
-
Iatrogenic Disease
-
Magnetic Resonance Imaging*
-
Middle Aged
-
Polysaccharides
-
Postoperative Care
-
Radiotherapy Dosage
-
Tamoxifen / administration & dosage
-
Tamoxifen / adverse effects*
-
Time Factors
-
Ultrasonography
Substances
-
Antineoplastic Agents, Hormonal
-
Contrast Media
-
Polysaccharides
-
Tamoxifen
-
SHU 508